Changsha Pinmaitongda Electronic Technology Co., Ltd. – Trademark Portfolio
Entity Type: 16
Changsha Pinmaitongda Electronic Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SOUYUZA. The owner is based in Hunan.
344, 2nd Floor, Hongxi Community Office Building
Hongshan Street, Kaifu District
Hunan 410000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Changsha Pinmaitongda Electronic Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Changsha Pinmaitongda Electronic Technology Co., Ltd. have?
Changsha Pinmaitongda Electronic Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Changsha Pinmaitongda Electronic Technology Co., Ltd. file in?
Changsha Pinmaitongda Electronic Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Changsha Pinmaitongda Electronic Technology Co., Ltd.'s most well-known trademarks?
Changsha Pinmaitongda Electronic Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as SOUYUZA. These are among 1 currently registered trademark in the portfolio.
What is Changsha Pinmaitongda Electronic Technology Co., Ltd.'s trademark registration success rate?
Changsha Pinmaitongda Electronic Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.